These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 19232095)

  • 41. Asymmetric dimethylarginine is closely associated with the development and progression of nephropathy in patients with type 2 diabetes.
    Hanai K; Babazono T; Nyumura I; Toya K; Tanaka N; Tanaka M; Ishii A; Iwamoto Y
    Nephrol Dial Transplant; 2009 Jun; 24(6):1884-8. PubMed ID: 19131352
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of addition of silymarin to renin-angiotensin system inhibitors on proteinuria in type 2 diabetic patients with overt nephropathy: a randomized, double-blind, placebo-controlled trial.
    Fallahzadeh MK; Dormanesh B; Sagheb MM; Roozbeh J; Vessal G; Pakfetrat M; Daneshbod Y; Kamali-Sarvestani E; Lankarani KB
    Am J Kidney Dis; 2012 Dec; 60(6):896-903. PubMed ID: 22770926
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Retinal vessel calibers predict long-term microvascular complications in type 1 diabetes: the Danish Cohort of Pediatric Diabetes 1987 (DCPD1987).
    Broe R; Rasmussen ML; Frydkjaer-Olsen U; Olsen BS; Mortensen HB; Hodgson L; Wong TY; Peto T; Grauslund J
    Diabetes; 2014 Nov; 63(11):3906-14. PubMed ID: 24914239
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Methotrexate withdrawal at 6 vs 12 months in juvenile idiopathic arthritis in remission: a randomized clinical trial.
    Foell D; Wulffraat N; Wedderburn LR; Wittkowski H; Frosch M; Gerss J; Stanevicha V; Mihaylova D; Ferriani V; Tsakalidou FK; Foeldvari I; Cuttica R; Gonzalez B; Ravelli A; Khubchandani R; Oliveira S; Armbrust W; Garay S; Vojinovic J; Norambuena X; Gamir ML; García-Consuegra J; Lepore L; Susic G; Corona F; Dolezalova P; Pistorio A; Martini A; Ruperto N; Roth J;
    JAMA; 2010 Apr; 303(13):1266-73. PubMed ID: 20371785
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serum Bicarbonate and Kidney Disease Progression and Cardiovascular Outcome in Patients With Diabetic Nephropathy: A Post Hoc Analysis of the RENAAL (Reduction of End Points in Non-Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan) Study and IDNT (Irbesartan Diabetic Nephropathy Trial).
    Schutte E; Lambers Heerspink HJ; Lutgers HL; Bakker SJ; Vart P; Wolffenbuttel BH; Umanath K; Lewis JB; de Zeeuw D; Gansevoort RT
    Am J Kidney Dis; 2015 Sep; 66(3):450-8. PubMed ID: 25987260
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nephropathy, but not Angiographically Proven Retinopathy, is Associated with Neutrophil to Lymphocyte Ratio in Patients with Type 2 Diabetes.
    Ciray H; Aksoy AH; Ulu N; Cizmecioglu A; Gaipov A; Solak Y
    Exp Clin Endocrinol Diabetes; 2015 May; 123(5):267-71. PubMed ID: 25853704
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Oral supplementation of turmeric attenuates proteinuria, transforming growth factor-β and interleukin-8 levels in patients with overt type 2 diabetic nephropathy: a randomized, double-blind and placebo-controlled study.
    Khajehdehi P; Pakfetrat M; Javidnia K; Azad F; Malekmakan L; Nasab MH; Dehghanzadeh G
    Scand J Urol Nephrol; 2011 Nov; 45(5):365-70. PubMed ID: 21627399
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serum cystatin C in diabetic patients. Not only an indicator for renal dysfunction in patients with overt nephropathy but also a predictor for cardiovascular events in patients without nephropathy.
    Ogawa Y; Goto T; Tamasawa N; Matsui J; Tando Y; Sugimoto K; Tomotsune K; Kimura M; Yasujima M; Suda T
    Diabetes Res Clin Pract; 2008 Feb; 79(2):357-61. PubMed ID: 17980929
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The association of plasma fibrinogen concentration with diabetic microvascular complications in young adults with early-onset of type 2 diabetes.
    Le DS; Miles R; Savage PJ; Cornell E; Tracy RP; Knowler WC; Krakoff J
    Diabetes Res Clin Pract; 2008 Dec; 82(3):317-23. PubMed ID: 18922595
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nonalbuminuric proteinuria as a biomarker for tubular damage in early development of nephropathy with type 2 diabetic patients.
    Kim SS; Song SH; Kim IJ; Kim WJ; Jeon YK; Kim BH; Kwak IS; Lee EK; Kim YK
    Diabetes Metab Res Rev; 2014 Nov; 30(8):736-41. PubMed ID: 24687388
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Three-month treatment with pioglitazone reduces circulating levels of S100A8/A9 (MRP8/14) complex, a biomarker of inflammation, without changes in body mass index, in type 2 diabetics with abdominal obesity.
    Nakatsuji H; Kishida K; Funahashi T; Shimomura I;
    Diabetes Res Clin Pract; 2012 Mar; 95(3):e58-60. PubMed ID: 22154375
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Type 2 diabetic patients with nephropathy show structural-functional relationships that are similar to type 1 disease.
    White KE; Bilous RW
    J Am Soc Nephrol; 2000 Sep; 11(9):1667-1673. PubMed ID: 10966491
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Proteinuria as a predictor of total plasma homocysteine levels in type 2 diabetic nephropathy.
    Friedman AN; Hunsicker LG; Selhub J; Bostom AG;
    Diabetes Care; 2002 Nov; 25(11):2037-41. PubMed ID: 12401753
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Plasma miR-193a-3p can be a potential biomarker for the diagnosis of diabetic nephropathy.
    Hong Y; Wang J; Zhang L; Sun W; Xu X; Zhang K
    Ann Clin Biochem; 2021 Mar; 58(2):141-148. PubMed ID: 33302703
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Elevated levels of interleukin-18 and tumor necrosis factor-alpha in serum of patients with type 2 diabetes mellitus: relationship with diabetic nephropathy.
    Moriwaki Y; Yamamoto T; Shibutani Y; Aoki E; Tsutsumi Z; Takahashi S; Okamura H; Koga M; Fukuchi M; Hada T
    Metabolism; 2003 May; 52(5):605-8. PubMed ID: 12759891
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of pitavastatin on urinary liver-type fatty acid-binding protein levels in patients with early diabetic nephropathy.
    Nakamura T; Sugaya T; Kawagoe Y; Ueda Y; Osada S; Koide H
    Diabetes Care; 2005 Nov; 28(11):2728-32. PubMed ID: 16249547
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diagnostic and prognostic value of myeloid-related protein complex 8/14 for sepsis.
    Gao S; Yang Y; Fu Y; Guo W; Liu G
    Am J Emerg Med; 2015 Sep; 33(9):1278-82. PubMed ID: 26206243
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Validity of biomarkers predicting onset or progression of nephropathy in patients with Type 2 diabetes: a systematic review.
    Hellemons ME; Kerschbaum J; Bakker SJ; Neuwirt H; Mayer B; Mayer G; de Zeeuw D; Lambers Heerspink HJ; Rudnicki M
    Diabet Med; 2012 May; 29(5):567-77. PubMed ID: 21913962
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association of low-grade inflammation with nephropathy in type 2 diabetic patients: role of elevated CRP-levels and 2 different gene-polymorphisms of proinflammatory cytokines.
    Abrahamian H; Endler G; Exner M; Mauler H; Raith M; Endler L; Rumpold H; Gerdov M; Mannhalter C; Prager R; Irsigler K; Wagner OF
    Exp Clin Endocrinol Diabetes; 2007 Jan; 115(1):38-41. PubMed ID: 17286233
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mean platelet volume and related factors in patients at different stages of diabetic nephropathy: a preliminary study.
    Turgutalp K; Özhan O; Akbay E; Tombak A; Tiftik N; Ozcan T; Yilmaz S; Helvaci I; Kiykim A
    Clin Appl Thromb Hemost; 2014 Mar; 20(2):190-5. PubMed ID: 22914809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.